Overview
Multi-stage venture capital firm investing across technology sectors. Managing Partner Mark Leschly began with a healthcare focus and has backed numerous biotechnology, pharmaceutical and medical-technology companies, including Anacor, Dendreon, Human Genome Sciences, MedImmune and Vanda.
Unlock the full profileGet the complete company dossier
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.